Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12

Release time:2023-05-18|Hits:

Affiliation of Author(s):基础医学院

Journal:NATURE COMMUNICATIONS

First Author:王子翔

Document Code:40EBF5AEE4A145C4A075F8E2CCC99567

Issue:13(1):6246

Number of Words:10

Translation or Not:no

Date of Publication:2022-10-21